KPMG Global Life Sciences CEO Outlook

Executives are optimistic about growth, increasingly focusing on M&A and AI, and continuing to develop new working models.

We surveyed CEOs in the life sciences industry worldwide about their goals, priorities, and expectations.

The key findings at a glance:

83 percent of respondents are positive about the industry's growth opportunities.
86 percent plan to engage in moderate to high levels of M&A activity.
85 percent believe that their employees' AI fitness has an impact on their growth targets.
Nearly three-quarters expect hybrid working models for the majority of their workforce.
80 percent expect AI to help them reduce emissions and improve energy efficiency.

The results provide guidance and show what priorities CEOs are setting now – and what developments will influence the industry in the coming years.